pharmazz

  • Pharmazz, Inc. initiates human phase II studies of PMZ-2010 for the treatment of hemorrhagic shock and presents data at the Society of Critical Care Medicine Annual Meeting

    Feb 3, 2017 - Additional information may be found on the Company's website, www.pharmazz.com. Forward-Looking Statements This press release contains ...
    Read More
  • Pharmazz, Inc. advances its product pipeline for the treatment of stroke, strengthens patent portfolio and presents hemorrhagic shock data at the American Heart Association

    Nov 30, 2016 - Additional information may be found on the Company's website, www.pharmazz.com. Forward-Looking Statements This press release contains ...
    Read More
  • Pharmazz, Inc. strengthens its patent portfolio with Notice of Issuance for PMZ-2123 (BQ123) in the treatment of diabetic ketoacidosis

    Apr 22, 2016 - NAPERVILLE, Ill., April 22, 2016 /PRNewswire/ -- Pharmazz, Inc. ... This press releasecontains "forward-looking statements" within the ...
    Read More